These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33850042)

  • 1. Quantifying the Evolutionary Constraints and Potential of Hepatitis C Virus NS5A Protein.
    Dai L; Du Y; Qi H; Huber CD; Chen D; Zhang TH; Wu NC; Wang E; Lloyd-Smith JO; Sun R
    mSystems; 2021 Apr; 6(2):. PubMed ID: 33850042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Two-Level, Intramutant Spectrum Haplotype Profile of Hepatitis C Virus Revealed by Self-Organized Maps.
    Delgado S; Perales C; García-Crespo C; Soria ME; Gallego I; de Ávila AI; Martínez-González B; Vázquez-Sirvent L; López-Galíndez C; Morán F; Domingo E
    Microbiol Spectr; 2021 Dec; 9(3):e0145921. PubMed ID: 34756074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution and persistence of resistance-associated substitutions of hepatitis C virus after direct-acting antiviral treatment failures.
    Jeong Y; Jin B; Lee HW; Park HJ; Park JY; Kim DY; Han KH; Ahn SH; Kim S
    J Viral Hepat; 2018 Nov; 25(11):1251-1259. PubMed ID: 29768695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational resilience of antiviral restriction favors primate TRIM5α in host-virus evolutionary arms races.
    Tenthorey JL; Young C; Sodeinde A; Emerman M; Malik HS
    Elife; 2020 Sep; 9():. PubMed ID: 32930662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell culture-adaptive mutations in hepatitis C virus promote viral production by enhancing viral replication and release.
    Wang Q; Li Y; Liu SA; Xie W; Cheng J
    World J Gastroenterol; 2018 Mar; 24(12):1299-1311. PubMed ID: 29599605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dehydrojuncusol, a Natural Phenanthrene Compound Extracted from
    Sahuc ME; Sahli R; Rivière C; Pène V; Lavie M; Vandeputte A; Brodin P; Rosenberg AR; Dubuisson J; Ksouri R; Rouillé Y; Sahpaz S; Séron K
    J Virol; 2019 May; 93(10):. PubMed ID: 30842319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective characterization of full-length hepatitis C virus NS5A quasispecies during induction and combination antiviral therapy.
    Nousbaum J; Polyak SJ; Ray SC; Sullivan DG; Larson AM; Carithers RL; Gretch DR
    J Virol; 2000 Oct; 74(19):9028-38. PubMed ID: 10982347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa.
    Zeuzem S; Lee JH; Roth WK
    Hepatology; 1997 Mar; 25(3):740-4. PubMed ID: 9049228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HCV genotype 1-6 NS3 residue 80 substitutions impact protease inhibitor activity and promote viral escape.
    Pham LV; Jensen SB; Fahnøe U; Pedersen MS; Tang Q; Ghanem L; Ramirez S; Humes D; Serre SBN; Schønning K; Bukh J; Gottwein JM
    J Hepatol; 2019 Mar; 70(3):388-397. PubMed ID: 30395912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmission genetics of drug-resistant hepatitis C virus.
    van Buuren N; Tellinghuisen TL; Richardson CD; Kirkegaard K
    Elife; 2018 Mar; 7():. PubMed ID: 29589830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus resistance to protease inhibitors.
    Halfon P; Locarnini S
    J Hepatol; 2011 Jul; 55(1):192-206. PubMed ID: 21284949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell culture-adaptive mutations promote viral protein-protein interactions and morphogenesis of infectious hepatitis C virus.
    Jiang J; Luo G
    J Virol; 2012 Sep; 86(17):8987-97. PubMed ID: 22674987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline resistance associated substitutions in HCV genotype 1 infected cohort treated with Simeprevir, Daclatasvir and Sofosbuvir in Brazil.
    Aguiar BF; Campos GRF; Rodrigues JPV; Marques NN; Molina BF; Bittar C; Souza FF; Martinelli ALC; Rahal P; Pereira LRL
    Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):329-339. PubMed ID: 31523019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral RNA mutations are region specific and increased by ribavirin in a full-length hepatitis C virus replication system.
    Contreras AM; Hiasa Y; He W; Terella A; Schmidt EV; Chung RT
    J Virol; 2002 Sep; 76(17):8505-17. PubMed ID: 12163570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel drug resistance-associated substitutions against pibrentasvir emerged in genotype 1b hepatitis C virus-infected human hepatocyte transplanted mice.
    Ohya K; Imamura M; Teraoka Y; Uchida T; Fujino H; Nakahara T; Ono A; Murakami E; Yamauchi M; Kawaoka T; Miki D; Tsuge M; Abe-Chayama H; Hayes CN; Aikata H; Ishida Y; Tateno C; Song H; Miyayama Y; Hijikata M; Chayama K
    Biochem Biophys Res Commun; 2021 Jun; 559():78-83. PubMed ID: 33932902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of glecaprevir and pibrentasvir treatment for genotype 1b hepatitis C virus drug resistance-associated variants in humanized mice.
    Osawa M; Uchida T; Imamura M; Teraoka Y; Fujino H; Nakahara T; Ono A; Murakami E; Kawaoka T; Miki D; Tsuge M; Hiramatsu A; Abe-Chayama H; Hayes CN; Makokha GN; Aikata H; Ishida Y; Tateno C; Miyayama Y; Hijikata M; Chayama K
    J Gen Virol; 2019 Jul; 100(7):1123-1131. PubMed ID: 31199224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replicons of a Rodent Hepatitis C Model Virus Permit Selection of Highly Permissive Cells.
    Wolfisberg R; Holmbeck K; Nielsen L; Kapoor A; Rice CM; Bukh J; Scheel TKH
    J Virol; 2019 Oct; 93(19):. PubMed ID: 31292246
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Lloren KKS; Kwon JJ; Choi WS; Jeong JH; Ahn SJ; Choi YK; Baek YH; Song MS
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30602610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Broad and Dynamic Diversification of Infectious Hepatitis C Virus in a Cell Culture Environment.
    Gallego I; Soria ME; García-Crespo C; Chen Q; Martínez-Barragán P; Khalfaoui S; Martínez-González B; Sanchez-Martin I; Palacios-Blanco I; de Ávila AI; García-Cehic D; Esteban JI; Gómez J; Briones C; Gregori J; Quer J; Perales C; Domingo E
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31852791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased replicative fitness can lead to decreased drug sensitivity of hepatitis C virus.
    Sheldon J; Beach NM; Moreno E; Gallego I; Piñeiro D; Martínez-Salas E; Gregori J; Quer J; Esteban JI; Rice CM; Domingo E; Perales C
    J Virol; 2014 Oct; 88(20):12098-111. PubMed ID: 25122776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.